ZA744409B - New derivatives of 2-benzamido-5-nitro-thiazoles - Google Patents

New derivatives of 2-benzamido-5-nitro-thiazoles

Info

Publication number
ZA744409B
ZA744409B ZA00744409A ZA744409A ZA744409B ZA 744409 B ZA744409 B ZA 744409B ZA 00744409 A ZA00744409 A ZA 00744409A ZA 744409 A ZA744409 A ZA 744409A ZA 744409 B ZA744409 B ZA 744409B
Authority
ZA
South Africa
Prior art keywords
benzamido
thiazoles
nitro
new derivatives
derivatives
Prior art date
Application number
ZA00744409A
Other languages
English (en)
Inventor
J Rossignol
R Cavier
Original Assignee
Phavic Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phavic Sprl filed Critical Phavic Sprl
Publication of ZA744409B publication Critical patent/ZA744409B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/58—Nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA00744409A 1973-08-08 1974-07-09 New derivatives of 2-benzamido-5-nitro-thiazoles ZA744409B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3760873A GB1437800A (en) 1973-08-08 1973-08-08 Derivatives of 2-benzamido-5-nitro-thiazoles

Publications (1)

Publication Number Publication Date
ZA744409B true ZA744409B (en) 1975-07-30

Family

ID=10397712

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00744409A ZA744409B (en) 1973-08-08 1974-07-09 New derivatives of 2-benzamido-5-nitro-thiazoles

Country Status (14)

Country Link
US (1) US3950351A (fr)
JP (1) JPS5041858A (fr)
AR (1) AR201880A1 (fr)
BE (1) BE817878A (fr)
CA (1) CA1041519A (fr)
CH (1) CH583215A5 (fr)
DE (1) DE2438037C2 (fr)
ES (1) ES428906A1 (fr)
FR (1) FR2240010B1 (fr)
GB (1) GB1437800A (fr)
IL (1) IL45194A (fr)
NL (1) NL176779C (fr)
OA (1) OA04761A (fr)
ZA (1) ZA744409B (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2435905A1 (fr) * 1978-09-13 1980-04-11 Anvar Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
EP0031563B1 (fr) * 1979-12-21 1983-09-14 The Wellcome Foundation Limited Nitrothiazolines, leur préparation et compositions pharmaceutiques les contenant
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
PT755386E (pt) * 1994-04-13 2002-11-29 Romark Lab Lc Derivado de benzamida composicoes contendo o referido derivado e sua utilizacao
US5968961A (en) * 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A (en) * 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
MX9604483A (es) * 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
AU756451B2 (en) * 1997-05-07 2003-01-16 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
ES2232687T3 (es) * 1997-05-07 2005-06-01 Romark Laboratories, L.C. Composiciones farmaceuticas de tizoxanida y/o nitazoxanida.
US5935591A (en) * 1998-01-15 1999-08-10 Romark Laboratories, L.C. Method for treatment of equine protozoal myeloencephalitis with thiazolides
US5925622A (en) * 1998-07-13 1999-07-20 Romark Laboratories, L.C. Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0325402D0 (en) * 2003-10-31 2003-12-03 Astrazeneca Ab Compounds
GB0327761D0 (en) * 2003-11-29 2003-12-31 Astrazeneca Ab Compounds
GB0328178D0 (en) * 2003-12-05 2004-01-07 Astrazeneca Ab Compounds
DE602005013491D1 (de) * 2004-02-18 2009-05-07 Astrazeneca Ab Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
KR20070007104A (ko) * 2004-02-18 2007-01-12 아스트라제네카 아베 화합물
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
UA90864C2 (en) 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20060194853A1 (en) * 2004-10-08 2006-08-31 Rossignol Jean F Alkyl benzamides
KR20070085371A (ko) 2004-10-16 2007-08-27 아스트라제네카 아베 페녹시 벤즈아미드 화합물의 제조 방법
GB0423044D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
CA2604640A1 (fr) * 2005-04-12 2006-10-19 Romark Laboratories L.C. Procedes pour traiter des maladies par interruption de la maturation de proteines, composes qui inhibent la fonction de chaperons moleculaires tels que des isomerases de disulfureproteiques ou qui interferent avec la glycosylation, compositions pharmaceutiques comprenant ces composes et procedes de criblage pour identifier
EP1891069A1 (fr) * 2005-05-24 2008-02-27 AstraZeneca AB Derives d'imidazol[4,5b]pyridine/pyrazine et purine substitues en 2-phenyl en tant que modulateurs de la glucokinase
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
CA2614746C (fr) * 2005-07-09 2011-05-10 Astrazeneca Ab Derives d'heteroaryl benzamide utilises en tant qu'activateurs de la glk dans le traitement du diabete
US20110053910A1 (en) * 2005-07-09 2011-03-03 Mckerrecher Darren 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
US20080234273A1 (en) * 2005-07-09 2008-09-25 Mckerrecher Darren Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
TW200738621A (en) * 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
AP2907A (en) 2006-01-09 2014-05-31 Romark Lab Lc Viral hepatitis treatment
WO2008008480A2 (fr) * 2006-07-12 2008-01-17 Cumbre Pharmaceuticals Inc. Dérivés de rifamycine contenant du nitrohétéroaryl
CN100465169C (zh) * 2006-08-02 2009-03-04 杭州欣阳三友精细化工有限公司 硝唑尼特的制备方法
TW200825063A (en) * 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (ar) * 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
UY30822A1 (es) * 2006-12-21 2008-07-31 Astrazeneca Ab Fnueva forma cristalina de 3-{[5-azetidin-1-ylcabonyl)pyrazin-2-yl]oxy}-5-[1-methylethyloxy]-n-1h-pyrazol-3-ylbenzamida, composiciones conteniéndola, procesos de preparacion y aplicaciones
CN101007792B (zh) * 2007-01-31 2010-05-26 浙江大学 一种合成硝基噻唑苯酰胺化合物的方法
EP2178852B9 (fr) 2007-08-03 2016-06-22 Romark Laboratories, L.C. Composés thiazolide à substitution alkylsulfonyle
CA2732165A1 (fr) * 2008-08-04 2010-02-11 Astrazeneca Ab Agents therapeutiques 414
ES2467108T3 (es) 2008-12-09 2014-06-11 Gilead Sciences, Inc. Moduladores de receptores tipo toll
US8524278B2 (en) 2009-02-13 2013-09-03 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
PE20121118A1 (es) * 2009-05-12 2012-09-05 Romark Lab Lc Compuestos de haloalquil heteroaril benzamida
AP2012006064A0 (en) 2009-06-26 2012-02-29 Romark Lab Lc Compounds and methods for treating influenza.
CN101602744B (zh) * 2009-06-30 2011-06-01 青岛康地恩药业有限公司 一种硝唑尼特的制备方法
US9498441B2 (en) 2012-01-27 2016-11-22 Siegfried Rhein S.A. De C.V. Nitazoxadine composition and process to prepare same
EP2902024B1 (fr) 2012-09-27 2017-11-29 Siegfried Rhein S.A. De C.V. Composition synergique de nitazoxanide et de mébendazole, procédés de préparation correspondants et utilisation de cette composition dans le traitement de la parasitose humaine
WO2014205414A1 (fr) * 2013-06-21 2014-12-24 The Regents Of The University Of California Potentiel thérapeutique étendu dans des antimicrobiens à nitrohétéroaryle
PT3166607T (pt) 2014-07-11 2022-12-07 Gilead Sciences Inc Moduladores de receptores de tipo toll para o tratamento do vih
CA2960436C (fr) 2014-09-16 2021-01-05 Gilead Sciences, Inc. Formes solides d'un modulateur de recepteurs de type toll
CN107105660A (zh) 2014-11-11 2017-08-29 罗马克实验室有限公司 使用替唑尼特、其类似物或盐的前药的治疗组合物和治疗方法
CN105175352A (zh) * 2015-10-27 2015-12-23 杭州澳医保灵药业有限公司 一种硝唑尼特的制备方法
CN106831640A (zh) * 2015-12-03 2017-06-13 江苏正大丰海制药有限公司 一种硝唑尼特晶体的制备方法
CN108289961A (zh) 2016-03-31 2018-07-17 罗马克实验室有限公司 用于治疗病毒性感染的噻唑化物化合物
EA202191466A1 (ru) 2016-04-11 2021-12-31 Женфит Способы лечения холестатических и фибротических заболеваний
SG11201906041QA (en) 2017-01-27 2019-08-27 Genfit Pharmaceutical compositions for combination therapy
US11173149B2 (en) 2017-04-18 2021-11-16 Romark Laboratories L.C. Inhibition of protein disulfide-isomerase A3
WO2019241376A1 (fr) 2018-06-14 2019-12-19 The Trustees Of Columbia University In The City Of New York Traitement de troubles cognitifs à l'aide de nitazoxanide (ntz), d'analogues de nitazoxanide (ntz) et de leurs métabolites
CA3130518A1 (fr) 2019-04-12 2020-10-15 Nicolas STANKOVIC-VALENTIN Nitazoxanide et thiazolides destines a etre utilises dans le traitement de maladies associees au stress oxydatif
CA3153784A1 (fr) 2019-10-28 2021-05-06 Nicolas STANKOVIC-VALENTIN Polytherapie d'elafibranor et de nitazoxanide comportant des caracteristiques antioxydantes
EP4182304A1 (fr) 2020-07-20 2023-05-24 Romark Laboratories, L.C. Sels cristallins de tizoxanide et de 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) avec de l'éthanolamine, de la morpholine, de la propanolamine, de la pipérazine et de la n-méthylpipérazine
MX2023002208A (es) 2020-08-24 2023-05-17 Romark Laboratories Lc Uso de tiazolidas contra los coronavirus.
CN114044761B (zh) * 2021-02-24 2022-05-17 成都贝诺科成生物科技有限公司 一种新的硝基噻唑衍生物及其应用
CN115197164B (zh) * 2021-04-12 2025-04-01 杜心赟 新型噻唑类化合物及其制备方法和用途
DE112022004799T5 (de) 2021-10-05 2024-08-14 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Verbessertes Verfahren zur Herstellung von Nitazoxanid und Zwischenprodukten davon
WO2023198095A1 (fr) * 2022-04-12 2023-10-19 成都贝诺科成生物科技有限公司 Utilisation d'un dérivé de nitrothiazole dans la préparation d'un bactériostatique pour inhiber helicobacter pylori

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2829084A (en) * 1958-04-01 Certain alkyl-n
CA497537A (fr) * 1953-11-10 H. Clark Joe Amino-5-nitrothiazoles 2-substitues
US2735798A (en) * 1956-02-21 Acyl amevo-nitrothiazole compositions
US2401522A (en) * 1942-04-17 1946-06-04 Firm Sandoz Ltd Aromatic carboxylic acid amides and a process for their manufacture
GB577418A (en) * 1942-04-17 1946-05-17 Sandoz Ltd Process for the preparation of amides of aromatic carboxylic acids
FR1306603A (fr) * 1958-08-14 1962-10-19 Innothera Lab Sa Dérivés thiazoliques et leur procédé de préparation
US3475446A (en) * 1967-06-27 1969-10-28 Parke Davis & Co N-(5-nitro-2-thiazolyl)-cycloalkanecarboxamides

Also Published As

Publication number Publication date
JPS5041858A (fr) 1975-04-16
IL45194A (en) 1977-10-31
FR2240010A1 (fr) 1975-03-07
FR2240010B1 (fr) 1978-03-24
NL7409321A (nl) 1975-02-11
US3950351A (en) 1976-04-13
AR201880A1 (es) 1975-04-24
IL45194A0 (en) 1974-10-22
NL176779B (nl) 1985-01-02
OA04761A (fr) 1980-08-31
GB1437800A (en) 1976-06-03
CA1041519A (fr) 1978-10-31
NL176779C (nl) 1985-06-03
DE2438037A1 (de) 1975-02-20
ES428906A1 (es) 1976-08-16
DE2438037C2 (de) 1982-06-09
AU7135574A (en) 1976-01-22
BE817878A (fr) 1975-01-20
CH583215A5 (fr) 1976-12-31

Similar Documents

Publication Publication Date Title
ZA744409B (en) New derivatives of 2-benzamido-5-nitro-thiazoles
HK13379A (en) Pyrazino-isoquinoline derivatives
CS181861B1 (en) Mode of production of 7-hydroxy-5-methylisoflavon derivatives
PH14530A (en) 7-methoxycephalosporin derivatives
IL45129A0 (en) N-aminosulfenylated derivatives of carbofuran
PH12927A (en) Vingamine derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
IL43704A0 (en) Lactamimide derivatives
ZA745339B (en) New derivatives of 2-phenoxyacetamido-5-nitro-thiazole
JPS55153766A (en) Manufacture of 99substituted 33aminocarbazole derivative
HK23682A (en) Preparation of sulphonylbenzamide derivatives
IL45807A0 (en) Derivatives of 7alpha-methylester-4-ene-3alpha,17beta-diols
MY8100185A (en) Dihydroergopeptine derivatives
PH12303A (en) Thienotriazolodiazepine derivatives
HK181A (en) Benzylpyrimidine derivatives
ZA745927B (en) New derivatives of cyclopropylphenylprrolidnie
GB1407933A (en) Sulphenylation of n-arylheterocyclic compounds
AU7666474A (en) Derivatives of 1-phenoxy-3-aminopropan-2-/u
CY974A (en) Preparation of sulphonylbenzamide derivatives
IL44831A0 (en) Pyrazinoisoquinoline derivatives
CA1033741A (fr) Derives de la 4-hydroxy-5-azacoumarine
HK38779A (en) Derivatives of tryptophan
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives